Moreover, HIC1 synergized with PD‐L1 to suppress tumorigenesis in 615‐line mice models, indicating that elevated HIC1 expression may render tumor cells more responsive to PD‐L1 therapy. This evidence concerns the gene HIC1 and neoplasm.